Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis
Authors:
- 18 July 2011
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (31) , 12857-12862
Abstract
Autoimmune diseases, such as rheumatoid arthritis, frequently target one major tissue/organ despite the systemic nature of the immune response. This is particularly perplexing in the case of ubiquitously distributed antigens invoked in arthritis induction. We reasoned that selective targeting of the synovial joints in autoimmune arthritis might be due in part to the unique attributes of the joint vasculature. We examined this proposition using the adjuvant-induced arthritis model of human rheumatoid arthritis, and profiled the synovial vasculature using ex vivo and in vivo screening of a defined phage peptide-display library. We identified phage that preferentially homed to the inflamed joints. The corresponding synthetic peptides showed binding to the joint-derived endothelial cells, as well as specificity in inhibiting binding of the respective phage to the synovial vasculature. Intriguingly, the treatment of arthritic rats with one such peptide resulted in efficient inhibition of the progression of arthritis. The suppression of arthritis was attributable in part to the peptide-induced reduction of T-cell trafficking into the joints and the inhibition of angiogenesis. This peptide differed in sequence, in receptor binding specificity, and in angiogenesis/inflammation-related cell signaling from the previously characterized arginine-glycine-aspartic acid-containing peptide. Thus, our study reveals joint-homing peptides that can be further exploited for the selective delivery of antiarthritic agents into the inflamed joints to enhance their efficacy while reducing systemic toxicity, and also for examining intricacies of the pathogenesis of arthritis. This approach can be customized for application to other organ-specific autoimmune diseases as well.Keywords
This publication has 38 references indexed in Scilit:
- Synergistic Effect of Antiangiogenic Nanotherapy Combined with Methotrexate in The Treatment of Experimental Inflammatory ArthritisNanomedicine, 2010
- A novel melanoma-targeting peptide screened by phage display exhibits antitumor activityJournal of Molecular Medicine, 2010
- Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical ApplicationsCurrent Pharmaceutical Design, 2010
- Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapyNature Medicine, 2009
- Immune-mediated pathways in chronic inflammatory arthritisBest Practice & Research Clinical Rheumatology, 2008
- Angiogenesis inhibition as a therapeutic approach for inflammatory synovitisNature Clinical Practice Rheumatology, 2007
- Particularities of the vasculature can promote the organ specificity of autoimmune attackNature Immunology, 2006
- Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synoviumMolecular Therapy, 2003
- Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculatureProceedings of the National Academy of Sciences, 2002
- Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor PropertiesJournal of Biological Chemistry, 2000